speb/financial-data huggingface dataset:
IRMD balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 206009.00
IRMD income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 513000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Other Properties: 59221.00
IRMD balance_sheet (quarterly, 2025-03-31) — Payables: 3430432.00
IRMD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 5697074.00
IRMD income_statement (quarterly, 2025-03-31) — Pretax Income: 5945000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IRMD cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -53000.00
IRMD cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3697000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Raw Materials: 8937867.00
IRMD balance_sheet (quarterly, 2025-03-31) — Receivables: 12706192.00
IRMD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4668000.00
IRMD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 194000.00
IRMD income_statement (quarterly, 2025-03-31) — Research And Development: 624000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 59316658.00
IRMD income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4176000.00
IRMD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 8787000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Share Issued: 12715109.00
IRMD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 826000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 90054430.00
IRMD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 86795671.00
IRMD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IRMD income_statement (quarterly, 2025-03-31) — Tax Provision: 1258000.00
IRMD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
IRMD balance_sheet (quarterly, 2025-03-31) — Total Assets: 101729435.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 90054430.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Debt: 59221.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 90054430.00
IRMD income_statement (quarterly, 2025-03-31) — Total Expenses: 14079000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11675005.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 26592670.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3201561.00
IRMD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 5432000.00
IRMD balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 840388.00
IRMD balance_sheet (quarterly, 2025-03-31) — Work In Process: 714655.00
IRMD balance_sheet (quarterly, 2025-03-31) — Working Capital: 66663321.00
IRMD income_statement (quarterly, 2025-06-30) — +Operating Expense: 9166995.00
IRMD income_statement (quarterly, 2025-06-30) — +Total Revenue: 20409400.00
IRMD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1900980.00
IRMD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10922134.00
IRMD balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -4847697.00
IRMD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 31371123.00
IRMD balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -241411.00
IRMD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 12715872.00
IRMD income_statement (quarterly, 2025-06-30) — Basic EPS: 0.45
IRMD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 50331000.00
IRMD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2824038.00
IRMD cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -187824.00
IRMD balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 0.00
IRMD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1272.00
IRMD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 52995781.00
IRMD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 52995781.00
IRMD cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2161150.00
IRMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2257441.00
IRMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2824038.00
IRMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 7746353.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -689425.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 943389.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -516354.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Inventory: -751227.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1413.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 792162.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Payable: -1205779.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -262390.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -710671.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1802488.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -516354.00
IRMD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 871775.00
IRMD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1802488.00
IRMD cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2664874.00
IRMD balance_sheet (quarterly, 2025-06-30) — Common Stock: 1272.00
IRMD cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2161150.00
IRMD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 94301386.00
IRMD balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 14799460.00
IRMD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4454408.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3210145.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Assets: 77372612.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3257556.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3257556.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 8814546.00
IRMD balance_sheet (quarterly, 2025-06-30) — Current Provisions: 121221.00
IRMD cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 133115.00
IRMD cash_flow (quarterly, 2025-06-30) — Deferred Tax: 133115.00
IRMD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 207598.00
IRMD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 207598.00
IRMD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 12835408.00
IRMD income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.45
IRMD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5773961.00
IRMD income_statement (quarterly, 2025-06-30) — EBIT: 6787997.00
IRMD income_statement (quarterly, 2025-06-30) — EBITDA: 6995595.00
IRMD cash_flow (quarterly, 2025-06-30) — End Cash Position: 52995781.00
IRMD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2257441.00
IRMD balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1756100.00
IRMD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4922315.00
IRMD cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 1161.00
IRMD income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4279993.00
IRMD balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 3374945.00
IRMD balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 11163545.00
IRMD balance_sheet (quarterly, 2025-06-30) — Gross PPE: 27785777.00
IRMD income_statement (quarterly, 2025-06-30) — Gross Profit: 15954992.00
IRMD cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2337082.00
IRMD balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -515892.00
IRMD balance_sheet (quarterly, 2025-06-30) — Inventory: 11200336.00
IRMD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 94301386.00
IRMD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2824038.00
IRMD balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 6253790.00
IRMD balance_sheet (quarterly, 2025-06-30) — Leases: 270486.00
IRMD balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 6462041.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income: 5773961.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5773961.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5773961.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5773961.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5773961.00
IRMD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 5774390.00
IRMD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5773961.00
IRMD cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -96291.00
IRMD balance_sheet (quarterly, 2025-06-30) — Net PPE: 22938080.00
IRMD cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2636214.00
IRMD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 90926441.00
IRMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2557353.00
IRMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3331557.00
IRMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 3331557.00
IRMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2557353.00
IRMD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6995595.00
IRMD income_statement (quarterly, 2025-06-30) — Normalized Income: 5773961.00
IRMD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 7746353.00
IRMD income_statement (quarterly, 2025-06-30) — Operating Income: 6787997.00
IRMD income_statement (quarterly, 2025-06-30) — Operating Revenue: 20409400.00
IRMD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 12720002.00
IRMD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1924955.00
IRMD income_statement (quarterly, 2025-06-30) — Other Gand A: 4279993.00
IRMD income_statement (quarterly, 2025-06-30) — Other Income Expense: 539247.00
IRMD balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3374945.00
IRMD balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 204499.00
IRMD income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 539247.00
IRMD balance_sheet (quarterly, 2025-06-30) — Payables: 2225624.00
IRMD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5435769.00
IRMD balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 329406.00
IRMD income_statement (quarterly, 2025-06-30) — Pretax Income: 7327244.00
IRMD balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
IRMD cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 27632.00
IRMD cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2636214.00
IRMD balance_sheet (quarterly, 2025-06-30) — Raw Materials: 9133205.00
IRMD balance_sheet (quarterly, 2025-06-30) — Receivables: 10922134.00
IRMD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4454408.00
IRMD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 207598.00
IRMD income_statement (quarterly, 2025-06-30) — Research And Development: 877362.00
IRMD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 62928991.00
IRMD income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 4009640.00
IRMD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8289633.00
IRMD balance_sheet (quarterly, 2025-06-30) — Share Issued: 12720002.00
IRMD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 730682.00
IRMD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 94301386.00
IRMD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 90926441.00
IRMD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IRMD income_statement (quarterly, 2025-06-30) — Tax Provision: 1553283.00
IRMD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
IRMD balance_sheet (quarterly, 2025-06-30) — Total Assets: 106447489.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 94301386.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Debt: 0.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 94301386.00
IRMD income_statement (quarterly, 2025-06-30) — Total Expenses: 13621403.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12146103.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 29074877.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3331557.00
IRMD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 6787997.00
IRMD balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 324644.00
IRMD balance_sheet (quarterly, 2025-06-30) — Work In Process: 826923.00
IRMD balance_sheet (quarterly, 2025-06-30) — Working Capital: 68558066.00
IRMD income_statement (quarterly, 2025-09-30) — +Operating Expense: 9660558.00
IRMD income_statement (quarterly, 2025-09-30) — +Total Revenue: 21202064.00
IRMD balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2333474.00
IRMD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 13858292.00
IRMD balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -4866515.00
IRMD balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 32007647.00
IRMD balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -191175.00
IRMD cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 127410.00
IRMD cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 127410.00
IRMD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 12720812.00
IRMD income_statement (quarterly, 2025-09-30) — Basic EPS: 0.44
IRMD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 52995781.00
IRMD balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 11526063.00
IRMD cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1263555.00
IRMD cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -125943.00
IRMD balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1272.00
IRMD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 56526151.00
IRMD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 56526151.00
IRMD cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2162591.00
IRMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -2192150.00
IRMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1263555.00
IRMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 6986074.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 432494.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 861031.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 2772533.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Inventory: -559684.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -9875.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 157647.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Payable: 3205027.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4066058.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -545379.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2885922.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 2772533.00
IRMD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 222845.00
IRMD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -2885922.00
IRMD cash_flow (quarterly, 2025-09-30) — Changes In Cash: 3530370.00
IRMD balance_sheet (quarterly, 2025-09-30) — Common Stock: 1272.00
IRMD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 98351971.00
IRMD balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 497451.00
IRMD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4707756.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4071176.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Assets: 84919005.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3158065.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3158065.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 12796917.00
IRMD balance_sheet (quarterly, 2025-09-30) — Current Provisions: 137025.00
IRMD cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 134872.00
IRMD cash_flow (quarterly, 2025-09-30) — Deferred Tax: 134872.00
IRMD cash_flow (quarterly, 2025-09-30) — Depreciation: 256312.00
IRMD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 383722.00
IRMD cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 383722.00
IRMD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 12860077.00
IRMD income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.43
IRMD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — EBIT: 6833750.00
IRMD income_statement (quarterly, 2025-09-30) — EBITDA: 7217472.00
IRMD cash_flow (quarterly, 2025-09-30) — End Cash Position: 56526151.00
IRMD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -2192150.00
IRMD balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1943369.00
IRMD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 5722520.00
IRMD cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 32991.00
IRMD income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4355636.00
IRMD balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3373478.00
IRMD balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 14049467.00
IRMD balance_sheet (quarterly, 2025-09-30) — Gross PPE: 28658956.00
IRMD income_statement (quarterly, 2025-09-30) — Gross Profit: 16494308.00
IRMD cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 153718.00
IRMD balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 2800970.00
IRMD balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -535038.00
IRMD balance_sheet (quarterly, 2025-09-30) — Inventory: 11734822.00
IRMD balance_sheet (quarterly, 2025-09-30) — Invested Capital: 98351971.00
IRMD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1263555.00
IRMD balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 9514323.00
IRMD balance_sheet (quarterly, 2025-09-30) — Leases: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 7121119.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 5576652.00
IRMD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 5576652.00
IRMD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 5576652.00
IRMD cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -29559.00
IRMD balance_sheet (quarterly, 2025-09-30) — Net PPE: 23792441.00
IRMD cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1137612.00
IRMD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 94978493.00
IRMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 2422481.00
IRMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3572891.00
IRMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 3572891.00
IRMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2422481.00
IRMD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7217472.00
IRMD income_statement (quarterly, 2025-09-30) — Normalized Income: 5576652.00
IRMD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 6986075.00
IRMD cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 32991.00
IRMD income_statement (quarterly, 2025-09-30) — Operating Income: 6833750.00
IRMD income_statement (quarterly, 2025-09-30) — Operating Revenue: 21202064.00
IRMD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12721156.00
IRMD balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1097330.00
IRMD income_statement (quarterly, 2025-09-30) — Other Gand A: 4355636.00
IRMD income_statement (quarterly, 2025-09-30) — Other Income Expense: 463976.00
IRMD balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3373478.00
IRMD balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 214374.00
IRMD income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 463976.00
IRMD balance_sheet (quarterly, 2025-09-30) — Payables: 5430651.00
IRMD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9501827.00
IRMD balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1702410.00
IRMD income_statement (quarterly, 2025-09-30) — Pretax Income: 7297726.00
IRMD cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IRMD cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -31090.00
IRMD cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1137612.00
IRMD balance_sheet (quarterly, 2025-09-30) — Raw Materials: 9590716.00
IRMD balance_sheet (quarterly, 2025-09-30) — Receivables: 13858292.00
IRMD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4707756.00
IRMD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 383722.00
IRMD income_statement (quarterly, 2025-09-30) — Research And Development: 674362.00
IRMD balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 66343052.00
IRMD income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4630560.00
IRMD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 8986196.00
IRMD balance_sheet (quarterly, 2025-09-30) — Share Issued: 12721156.00
IRMD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 666082.00
IRMD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 98351971.00
IRMD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 94978493.00
IRMD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IRMD income_statement (quarterly, 2025-09-30) — Tax Provision: 1721074.00
IRMD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
IRMD balance_sheet (quarterly, 2025-09-30) — Total Assets: 114721779.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 98351971.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Debt: 0.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 98351971.00
IRMD income_statement (quarterly, 2025-09-30) — Total Expenses: 14368314.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 16369808.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 29802774.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3572891.00
IRMD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 6833750.00
IRMD balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 3097177.00
IRMD balance_sheet (quarterly, 2025-09-30) — Work In Process: 735775.00
IRMD balance_sheet (quarterly, 2025-09-30) — Working Capital: 72122088.00
IRMD income_statement (annual, 2025-12-31) — +Operating Expense: 38177000.00
IRMD income_statement (quarterly, 2025-12-31) — +Operating Expense: 9938097.00
IRMD income_statement (annual, 2025-12-31) — +Total Revenue: 83814000.00
IRMD income_statement (quarterly, 2025-12-31) — +Total Revenue: 22691899.00
IRMD balance_sheet (annual, 2025-12-31) — Accounts Payable: 1820000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1820000.00
IRMD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 13667000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 13667000.00
IRMD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -5072000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -5072000.00
IRMD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 30386000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 30386000.00
IRMD balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -191000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -191000.00
IRMD cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 370000.00
IRMD cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 111020.00
IRMD cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 370000.00
IRMD cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 111020.00
IRMD income_statement (annual, 2025-12-31) — Basic Average Shares: 12722000.00
IRMD income_statement (quarterly, 2025-12-31) — Basic Average Shares: 12738000.00
IRMD income_statement (annual, 2025-12-31) — Basic EPS: 1.77
IRMD income_statement (quarterly, 2025-12-31) — Basic EPS: 0.51
IRMD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 52234000.00
IRMD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 56526151.00
IRMD balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 11526000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 11526000.00
IRMD cash_flow (annual, 2025-12-31) — Capital Expenditure: -8421000.00
IRMD cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -416407.00
IRMD cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -656000.00
IRMD cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -122233.00
IRMD balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
IRMD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 51159000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 51159000.00
IRMD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 51159000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 51159000.00
IRMD cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -15040000.00
IRMD cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -8554259.00
IRMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17601000.00
IRMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -10873409.00
IRMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8421000.00
IRMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -416407.00
IRMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 24947000.00
IRMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5922573.00
IRMD cash_flow (annual, 2025-12-31) — Change In Account Payable: -76000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -513069.00
IRMD cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -554000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -853420.00
IRMD cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 1964000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -970179.00
IRMD cash_flow (annual, 2025-12-31) — Change In Inventory: -1377000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Inventory: 53911.00
IRMD cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -40000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -24538.00
IRMD cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -150000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
IRMD cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 1622000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 125191.00
IRMD cash_flow (annual, 2025-12-31) — Change In Payable: 1888000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Payable: -1483248.00
IRMD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1334000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2336668.00
IRMD cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2707000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1956950.00
IRMD cash_flow (annual, 2025-12-31) — Change In Receivables: -3027000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Receivables: 191434.00
IRMD cash_flow (annual, 2025-12-31) — Change In Tax Payable: 1964000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -970179.00
IRMD cash_flow (annual, 2025-12-31) — Change In Working Capital: -4345000.00
IRMD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3947620.00
IRMD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3027000.00
IRMD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 191434.00
IRMD cash_flow (annual, 2025-12-31) — Changes In Cash: -1075000.00
IRMD cash_flow (quarterly, 2025-12-31) — Changes In Cash: -5367244.00
IRMD balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
IRMD cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -15040000.00
IRMD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 94618000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 94618000.00
IRMD balance_sheet (annual, 2025-12-31) — Construction In Progress: 23000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 23000.00
IRMD income_statement (annual, 2025-12-31) — Cost Of Revenue: 19490000.00
IRMD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5660005.00
IRMD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3218000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3218000.00
IRMD balance_sheet (annual, 2025-12-31) — Current Assets: 81203000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Assets: 81203000.00
IRMD balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2871000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2871000.00
IRMD balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2871000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2871000.00
IRMD balance_sheet (annual, 2025-12-31) — Current Liabilities: 10180000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10180000.00
IRMD balance_sheet (annual, 2025-12-31) — Current Provisions: 144000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Current Provisions: 144000.00
IRMD cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2727000.00
IRMD cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2329013.00
IRMD cash_flow (annual, 2025-12-31) — Deferred Tax: 2727000.00
IRMD cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2329013.00
IRMD cash_flow (annual, 2025-12-31) — Depreciation: 796000.00
IRMD cash_flow (quarterly, 2025-12-31) — Depreciation: 269660.00
IRMD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1166000.00
IRMD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 380680.00
IRMD cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1166000.00
IRMD cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 380680.00
IRMD income_statement (annual, 2025-12-31) — Diluted Average Shares: 12854000.00
IRMD income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 12875000.00
IRMD income_statement (annual, 2025-12-31) — Diluted EPS: 1.75
IRMD income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.50
IRMD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 6441958.00
IRMD income_statement (annual, 2025-12-31) — EBIT: 26147000.00
IRMD income_statement (quarterly, 2025-12-31) — EBIT: 7093797.00
IRMD income_statement (annual, 2025-12-31) — EBITDA: 27313000.00
IRMD income_statement (quarterly, 2025-12-31) — EBITDA: 7474477.00
IRMD cash_flow (annual, 2025-12-31) — End Cash Position: 51159000.00
IRMD cash_flow (quarterly, 2025-12-31) — End Cash Position: 51159000.00
IRMD cash_flow (annual, 2025-12-31) — Financing Cash Flow: -17601000.00
IRMD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -10873409.00
IRMD balance_sheet (annual, 2025-12-31) — Finished Goods: 1732000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1732000.00
IRMD cash_flow (annual, 2025-12-31) — Free Cash Flow: 16526000.00
IRMD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5506165.00
IRMD cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 37000.00
IRMD cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 2848.00
IRMD income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 203000.00
IRMD income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 2000.00
IRMD income_statement (annual, 2025-12-31) — General And Administrative Expense: 17782000.00
IRMD income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4535539.00
IRMD balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 3384000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 3384000.00
IRMD balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 13858000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 13858000.00
IRMD balance_sheet (annual, 2025-12-31) — Gross PPE: 28928000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28928000.00
IRMD income_statement (annual, 2025-12-31) — Gross Profit: 64324000.00
IRMD income_statement (quarterly, 2025-12-31) — Gross Profit: 17031894.00
IRMD cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3923000.00
IRMD cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1423200.00
IRMD balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1814000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1814000.00
IRMD income_statement (annual, 2025-12-31) — Interest Income: 2009000.00
IRMD income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2009000.00
IRMD balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -555000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -555000.00
IRMD balance_sheet (annual, 2025-12-31) — Inventory: 11620000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Inventory: 11620000.00
IRMD balance_sheet (annual, 2025-12-31) — Invested Capital: 94618000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 94618000.00
IRMD cash_flow (annual, 2025-12-31) — Investing Cash Flow: -8421000.00
IRMD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -416407.00
IRMD balance_sheet (annual, 2025-12-31) — Land And Improvements: 9514000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 9514000.00
IRMD balance_sheet (annual, 2025-12-31) — Leases: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 7865000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 7865000.00
IRMD income_statement (annual, 2025-12-31) — Net Income: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6441958.00
IRMD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 22480000.00
IRMD cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 22480000.00
IRMD income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 6441958.00
IRMD income_statement (annual, 2025-12-31) — Net Interest Income: 2009000.00
IRMD income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 2009000.00
IRMD cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2561000.00
IRMD cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2319150.00
IRMD balance_sheet (annual, 2025-12-31) — Net PPE: 23856000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Net PPE: 23856000.00
IRMD cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -7765000.00
IRMD cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -294174.00
IRMD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 91234000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 91234000.00
IRMD balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 94000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 94000.00
IRMD balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3978000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3978000.00
IRMD balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 3978000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 3978000.00
IRMD income_statement (annual, 2025-12-31) — Normalized EBITDA: 27108000.00
IRMD income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7474477.00
IRMD income_statement (annual, 2025-12-31) — Normalized Income: 22317435.00
IRMD income_statement (quarterly, 2025-12-31) — Normalized Income: 6441958.00
IRMD cash_flow (annual, 2025-12-31) — Operating Cash Flow: 24947000.00
IRMD cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5922572.00
IRMD cash_flow (annual, 2025-12-31) — Operating Gains Losses: 37000.00
IRMD cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2848.00
IRMD income_statement (annual, 2025-12-31) — Operating Income: 26147000.00
IRMD income_statement (quarterly, 2025-12-31) — Operating Income: 7093797.00
IRMD income_statement (annual, 2025-12-31) — Operating Revenue: 83814000.00
IRMD income_statement (quarterly, 2025-12-31) — Operating Revenue: 22691899.00
IRMD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12781774.00
IRMD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12781774.00
IRMD balance_sheet (annual, 2025-12-31) — Other Current Assets: 4757000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4757000.00
IRMD balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 313000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 313000.00
IRMD income_statement (annual, 2025-12-31) — Other Gand A: 17782000.00
IRMD income_statement (quarterly, 2025-12-31) — Other Gand A: 4535539.00
IRMD income_statement (annual, 2025-12-31) — Other Income Expense: 205000.00
IRMD income_statement (quarterly, 2025-12-31) — Other Income Expense: -1312196.00
IRMD balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3384000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3384000.00
IRMD balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 239000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 239000.00
IRMD balance_sheet (annual, 2025-12-31) — Payables: 3634000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Payables: 3634000.00
IRMD balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6852000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6852000.00
IRMD income_statement (annual, 2025-12-31) — Pretax Income: 28361000.00
IRMD income_statement (quarterly, 2025-12-31) — Pretax Income: 7790601.00
IRMD cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
IRMD cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Properties: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IRMD cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -37000.00
IRMD cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 19458.00
IRMD cash_flow (annual, 2025-12-31) — Purchase Of PPE: -7765000.00
IRMD cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -294174.00
IRMD balance_sheet (annual, 2025-12-31) — Raw Materials: 9612000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Raw Materials: 9612000.00
IRMD balance_sheet (annual, 2025-12-31) — Receivables: 13667000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Receivables: 13667000.00
IRMD income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 19490000.00
IRMD income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5660005.00
IRMD income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1166000.00
IRMD income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 380680.00
IRMD income_statement (annual, 2025-12-31) — Research And Development: 2975000.00
IRMD income_statement (quarterly, 2025-12-31) — Research And Development: 799031.00
IRMD balance_sheet (annual, 2025-12-31) — Retained Earnings: 64231000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 64231000.00
IRMD income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 17420000.00
IRMD income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 4603527.00
IRMD income_statement (annual, 2025-12-31) — Selling General And Administration: 35202000.00
IRMD income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9139066.00
IRMD balance_sheet (annual, 2025-12-31) — Share Issued: 12781774.00
IRMD balance_sheet (quarterly, 2025-12-31) — Share Issued: 12781774.00
IRMD income_statement (annual, 2025-12-31) — Special Income Charges: 203000.00
IRMD cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2919000.00
IRMD cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 696236.00
IRMD balance_sheet (annual, 2025-12-31) — Stockholders Equity: 94618000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 94618000.00
IRMD balance_sheet (annual, 2025-12-31) — Tangible Book Value: 91234000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 91234000.00
IRMD income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 42435.00
IRMD income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IRMD income_statement (annual, 2025-12-31) — Tax Provision: 5881000.00
IRMD income_statement (quarterly, 2025-12-31) — Tax Provision: 1348643.00
IRMD income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
IRMD income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
IRMD balance_sheet (annual, 2025-12-31) — Total Assets: 108776000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Assets: 108776000.00
IRMD balance_sheet (annual, 2025-12-31) — Total Capitalization: 94618000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 94618000.00
IRMD balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
IRMD balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 94618000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 94618000.00
IRMD income_statement (annual, 2025-12-31) — Total Expenses: 57667000.00
IRMD income_statement (quarterly, 2025-12-31) — Total Expenses: 15598102.00
IRMD balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14158000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14158000.00
IRMD balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 27573000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 27573000.00
IRMD balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3978000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3978000.00
IRMD income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 26147000.00
IRMD income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 7093797.00
IRMD balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1814000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1814000.00
IRMD income_statement (annual, 2025-12-31) — Total Unusual Items: 205000.00
IRMD income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 205000.00
IRMD balance_sheet (annual, 2025-12-31) — Work In Process: 831000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Work In Process: 831000.00
IRMD balance_sheet (annual, 2025-12-31) — Working Capital: 71023000.00
IRMD balance_sheet (quarterly, 2025-12-31) — Working Capital: 71023000.00
IRMD income_statement (quarterly, 2026-03-31) — +Operating Expense: 9577000.00
IRMD income_statement (quarterly, 2026-03-31) — +Total Revenue: 21979000.00
IRMD balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2182000.00
IRMD balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 13415000.00
IRMD balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5363000.00
IRMD balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 31020000.00
IRMD balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -231000.00
IRMD cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 164000.00